February 11, 2025 01:24 PM EST

FDA puts two Chinese API makers on import alert after failed inspections

Anna Brown

News Reporter

Chinese API manufacturers Wuhu Nuowei Chemistry and Chengdu Innovation Pharmaceutical have been placed on US import alert over issues with their quality control and testing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA puts two Chinese API makers on import alert after failed inspections

Anna Brown

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

What will pharma's share buyback shopping spree mean for M&A?

Pfizer’s prostate cancer data leak shows promising results in early-stage study

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

Inventiva cuts pipeline, lays off nearly entire research team in bid to get to Phase 3 MASH readout

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

FDA puts two Chi­nese API mak­ers on im­port alert af­ter failed in­spec­tions

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

FDA puts two Chinese API makers on import alert after failed inspections